UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032753
Receipt number R000037355
Scientific Title Studies on Alterations in Brain Function after Alcohol Administration Using MRI
Date of disclosure of the study information 2018/05/29
Last modified on 2022/04/19 11:51:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Acronym

Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Scientific Title

Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Scientific Title:Acronym

Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The objective of this study was to evaluate the effect of alcohol on the brain of healthy Japanese men and women aged 20 years or older and less than 30 years old, using MRI.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

MRI-measured data (T1, DTI, 1H-MRS, resting fMRI)
VAS score for subjective symptoms of drunkenness

Key secondary outcomes

Ethanol
Acetaldehyde
Acetic acid
Lactic acid
Pyruvic acid
Hematocrit
Plasma glucose
Plasma vasopressin
Plasma TGFBeta
Plasma amino acid


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Alcohol clamping method

Interventions/Control_2

Alcohol clamping method
Wash out
Controlled Trial

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

1.Age: 20 years or older, less than 30 years
2.Gender: Healthy Japanese men and women without disease
3.Right-handed person
4.Nonsmoker
5.Person who drink alcohol more frequently than once or twice a month.
6.Individuals with ALDH2 alcohol-susceptibility genes *1/*2

Key exclusion criteria

1.Patients with serious or past medical conditions of the heart, liver or kidney
2.Persons currently receiving continuous treatment with drugs
3.Persons with a history of drug or food allergy
4.Patients who are or have a history of treatment for drug dependence or abuse
5.Persons whose working hours are irregular, such as those who have worked at night
6.Subjects who are currently participating in another clinical study or have participated in another clinical study within the previous 3 months
7.Persons using cardiac pacemakers
8.Persons using vascular clips
9.Those using nerve electrical stimulators
10.Persons using implantable pumps
11.Persons in whom a piece of metal is in the body for some reason (including accidents and injuries)
12.Persons with tattoos (including one-point tattoos)
13.Persons with internal metal plates or screws for prostheses such as fractures
14.Other than the above, the investigator considered inappropriate for participation in the study

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Ochitani

Organization

HUMA R&D CORP

Division name

Clinical Development Division

Zip code

108-0014

Address

Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan

TEL

81-3-3431-1260

Email

ochitani@huma-rd.co.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Ochitani

Organization

HUMA R&D CORP

Division name

Clinical Development Division

Zip code

108-0014

Address

Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan

TEL

81-3-3431-1260

Homepage URL


Email

ochitani@huma-rd.co.jp


Sponsor or person

Institute

HUMA R&D CORP

Institute

Department

Personal name



Funding Source

Organization

Asahi Group Holdings,Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committees of Nihonbashi Egawa Clinic

Address

2F Kotobuki Build. 1-27-12 Yaesu Chuo-ku, Tokyo 103-0028 Japan

Tel

03-5204-0311

Email

jim@medipharma.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

18

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

The supply of materials used for analysis and measurement was delayed.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 11 Day

Date of IRB

2018 Year 05 Month 21 Day

Anticipated trial start date

2019 Year 05 Month 13 Day

Last follow-up date

2020 Year 12 Month 19 Day

Date of closure to data entry

2020 Year 12 Month 21 Day

Date trial data considered complete

2020 Year 12 Month 21 Day

Date analysis concluded

2022 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 05 Month 29 Day

Last modified on

2022 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037355


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name